Schedule 13G ownership disclosure

BELLICUM PHARMACEUTICALS INC

Security class unavailable · CUSIP: 079481107

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
12.6720%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000315066-17-001498
Form type
SC 13G/A
Filer
BELLICUM PHARMACEUTICALS, INC
CIK
CIK 1358403
Filed
Feb 14, 2017
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub